Patents Assigned to Biogaia AB
  • Patent number: 6454088
    Abstract: A two-part container in which a first compartment for a first component and having an upper and a lower layer is mounted either within or outside a second compartment, for a second component, at the location of a port on the second compartment. Cutting means are provided for cutting both the upper and lower layer and through the port, to release the first component into the second compartment.
    Type: Grant
    Filed: February 1, 2001
    Date of Patent: September 24, 2002
    Assignee: Biogaia AB
    Inventors: Bo Mollstam, Ivan A. Casas
  • Patent number: 5534253
    Abstract: A method of improving animal health including selecting at least one L. reuteri strain, characterized by the production of .beta.-hydroxypropionaldehyde, and using the selected strain(s) along with the antibiotic, gentamycin, as an animal treatment, for example, for newly hatched poultry.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 9, 1996
    Assignee: Biogaia AB
    Inventors: Ivan A. Casas, Bo Mollstam
  • Patent number: 5480641
    Abstract: A method of establishing direct feed microorganisms such as Lactobacillus reuteri in the gastrointestinal tract of avian organisms, in which the direct feed microorganisms are added to whey and fed in the form of pellets (compacted whey particles) to the organisms.
    Type: Grant
    Filed: June 15, 1993
    Date of Patent: January 2, 1996
    Assignee: Biogaia AB
    Inventor: Ivan A. Casas-Perez
  • Patent number: 5458875
    Abstract: A method of establishing direct feed microorganisms such as Lactobacillus reuteri in the gastrointestinal tract of avian organisms in which eggs are inoculated with living cells of the microorganism.
    Type: Grant
    Filed: December 1, 1994
    Date of Patent: October 17, 1995
    Assignee: Biogaia AB
    Inventors: Ivan A. Casas-Perez, Frank W. Edens
  • Patent number: 5413960
    Abstract: The antibiotic .beta.-hydroxypropionaldehyde is obtained by cultivating strains of Lactobacillus reuteri under anaerobic conditions in the presence of glycerol or glyceraldehyde. This antibiotic has activity against Gram positive and Gram negative bacteria, against the yeast, Saccharomyces cerevisiae, and against the protozoan, Trypanosoma cruzi, and decreases ribonucleotide reductase activity.
    Type: Grant
    Filed: July 27, 1993
    Date of Patent: May 9, 1995
    Assignee: Biogaia AB
    Inventors: Walter J. Dobrogosz, Sven E. Lindgren
  • Patent number: 5352586
    Abstract: The antibiotic reuterin is obtained by cultivating strains of Lactobacillus reuteri under controlled conditions. Reuterin has inhibitory activity against Gram positive and Gram negative bacteria, against yeast, Saccharomyces cerevisiae, and against the protozoan, Trypanosoma cruzi. Reuterin producing strains are identified by grown inhibition of susceptible microorganisms in the presence of glycerol or glyceraldehyde.
    Type: Grant
    Filed: March 18, 1991
    Date of Patent: October 4, 1994
    Assignee: Biogaia AB
    Inventors: Walter J. Dobrogosz, Sven E. Lindgren